Ilkka Ilonen, M.D., M.D.,Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Zenker Diverticulum | 2 | 2023 | 25 | 1.710 |
Why?
|
Pleural Neoplasms | 9 | 2023 | 621 | 1.610 |
Why?
|
Hernia, Hiatal | 4 | 2023 | 86 | 1.400 |
Why?
|
Mesothelioma | 8 | 2023 | 826 | 1.330 |
Why?
|
Thoracic Surgery, Video-Assisted | 5 | 2021 | 279 | 1.270 |
Why?
|
Lung Neoplasms | 23 | 2023 | 13196 | 1.120 |
Why?
|
Thoracotomy | 3 | 2019 | 358 | 1.050 |
Why?
|
Pneumonectomy | 5 | 2021 | 1107 | 1.030 |
Why?
|
Thymectomy | 2 | 2023 | 189 | 1.020 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 12 | 2023 | 5280 | 0.880 |
Why?
|
Finland | 7 | 2022 | 591 | 0.860 |
Why?
|
Esophageal Neoplasms | 7 | 2023 | 1617 | 0.800 |
Why?
|
Esophagoscopy | 1 | 2023 | 391 | 0.780 |
Why?
|
Dendritic Cell Sarcoma, Follicular | 1 | 2021 | 30 | 0.770 |
Why?
|
Peritoneal Neoplasms | 3 | 2020 | 686 | 0.660 |
Why?
|
Dialysis | 3 | 2008 | 75 | 0.660 |
Why?
|
Malpractice | 1 | 2023 | 550 | 0.640 |
Why?
|
Thymus Gland | 1 | 2023 | 1220 | 0.640 |
Why?
|
Digestive System Surgical Procedures | 1 | 2023 | 573 | 0.620 |
Why?
|
Liver Failure, Acute | 3 | 2008 | 174 | 0.570 |
Why?
|
Laparoscopy | 3 | 2023 | 2147 | 0.550 |
Why?
|
Gambling | 1 | 2018 | 252 | 0.470 |
Why?
|
Adenocarcinoma | 6 | 2023 | 6300 | 0.470 |
Why?
|
Radiographic Image Interpretation, Computer-Assisted | 1 | 2020 | 1181 | 0.440 |
Why?
|
Esophagectomy | 5 | 2023 | 459 | 0.420 |
Why?
|
Thoracic Surgical Procedures | 1 | 2014 | 344 | 0.360 |
Why?
|
Albumins | 3 | 2008 | 563 | 0.340 |
Why?
|
Insurance, Health | 1 | 2021 | 2473 | 0.330 |
Why?
|
Health Care Costs | 1 | 2021 | 3185 | 0.310 |
Why?
|
Cachexia | 2 | 2019 | 195 | 0.290 |
Why?
|
Multiple Organ Failure | 2 | 2006 | 387 | 0.280 |
Why?
|
Immunosorbent Techniques | 1 | 2006 | 177 | 0.280 |
Why?
|
Glutathione | 1 | 2009 | 562 | 0.270 |
Why?
|
Peroxidase | 1 | 2009 | 600 | 0.260 |
Why?
|
Retrospective Studies | 22 | 2023 | 78293 | 0.260 |
Why?
|
Quality of Life | 5 | 2020 | 12985 | 0.250 |
Why?
|
Respiratory Tract Infections | 1 | 2013 | 985 | 0.250 |
Why?
|
Survivors | 1 | 2014 | 2302 | 0.230 |
Why?
|
Asbestos | 2 | 2022 | 253 | 0.210 |
Why?
|
Aged | 26 | 2023 | 164222 | 0.200 |
Why?
|
Adenoviridae Infections | 1 | 2022 | 93 | 0.200 |
Why?
|
Osteonectin | 1 | 2021 | 33 | 0.190 |
Why?
|
Dendritic Cells, Follicular | 1 | 2021 | 51 | 0.190 |
Why?
|
Antineoplastic Agents | 2 | 2023 | 13531 | 0.180 |
Why?
|
Neoplasm Staging | 8 | 2022 | 11064 | 0.180 |
Why?
|
Receptor, Platelet-Derived Growth Factor beta | 1 | 2021 | 186 | 0.180 |
Why?
|
Survival Analysis | 6 | 2021 | 10127 | 0.180 |
Why?
|
Humans | 47 | 2023 | 746070 | 0.180 |
Why?
|
Epithelioid Cells | 1 | 2020 | 63 | 0.170 |
Why?
|
Cytokines | 4 | 2022 | 7219 | 0.170 |
Why?
|
Female | 33 | 2023 | 382129 | 0.170 |
Why?
|
Treatment Outcome | 9 | 2023 | 63664 | 0.170 |
Why?
|
Learning Curve | 1 | 2021 | 228 | 0.170 |
Why?
|
Funnel Chest | 1 | 2020 | 73 | 0.160 |
Why?
|
Male | 30 | 2023 | 351098 | 0.160 |
Why?
|
Middle Aged | 25 | 2023 | 214419 | 0.160 |
Why?
|
Reoperation | 3 | 2023 | 4215 | 0.160 |
Why?
|
Oncolytic Viruses | 1 | 2022 | 333 | 0.160 |
Why?
|
Thorax | 1 | 2021 | 543 | 0.150 |
Why?
|
Activins | 1 | 2019 | 212 | 0.150 |
Why?
|
Platinum | 1 | 2019 | 228 | 0.150 |
Why?
|
Cohort Studies | 6 | 2023 | 40505 | 0.150 |
Why?
|
Thoracic Wall | 1 | 2020 | 199 | 0.150 |
Why?
|
Oxidative Stress | 1 | 2009 | 3025 | 0.150 |
Why?
|
Myasthenia Gravis | 1 | 2020 | 206 | 0.150 |
Why?
|
Carcinoma, Squamous Cell | 2 | 2012 | 3984 | 0.140 |
Why?
|
Follow-Up Studies | 11 | 2020 | 38752 | 0.140 |
Why?
|
Oncolytic Virotherapy | 1 | 2022 | 505 | 0.140 |
Why?
|
Interleukin-2 | 1 | 2023 | 1868 | 0.140 |
Why?
|
Disintegrins | 1 | 2016 | 27 | 0.140 |
Why?
|
Carcinoid Tumor | 1 | 2018 | 227 | 0.130 |
Why?
|
Liver Transplantation | 2 | 2006 | 2204 | 0.130 |
Why?
|
Prognosis | 10 | 2022 | 29072 | 0.130 |
Why?
|
Deglutition Disorders | 1 | 2021 | 610 | 0.130 |
Why?
|
Mediastinal Neoplasms | 1 | 2018 | 402 | 0.120 |
Why?
|
Depression | 1 | 2014 | 7826 | 0.120 |
Why?
|
Pharmaceutical Preparations | 1 | 2023 | 1071 | 0.120 |
Why?
|
Lymphatic Metastasis | 2 | 2019 | 2917 | 0.120 |
Why?
|
Remission Induction | 1 | 2020 | 2361 | 0.120 |
Why?
|
ADAM Proteins | 1 | 2016 | 240 | 0.120 |
Why?
|
Aged, 80 and over | 13 | 2019 | 57552 | 0.120 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2023 | 2055 | 0.110 |
Why?
|
Adult | 17 | 2023 | 214969 | 0.110 |
Why?
|
Muscle, Skeletal | 2 | 2018 | 4863 | 0.110 |
Why?
|
Sarcopenia | 1 | 2018 | 362 | 0.110 |
Why?
|
Cell Line, Tumor | 3 | 2023 | 16652 | 0.100 |
Why?
|
Barrett Esophagus | 1 | 2016 | 492 | 0.100 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2023 | 4335 | 0.100 |
Why?
|
Occupational Exposure | 1 | 2022 | 1800 | 0.100 |
Why?
|
Postoperative Complications | 5 | 2023 | 15341 | 0.100 |
Why?
|
Peptide Library | 1 | 2012 | 350 | 0.100 |
Why?
|
Forecasting | 1 | 2020 | 2906 | 0.090 |
Why?
|
Neoadjuvant Therapy | 2 | 2022 | 2787 | 0.090 |
Why?
|
Necrosis | 2 | 2020 | 1593 | 0.090 |
Why?
|
Registries | 3 | 2020 | 8170 | 0.080 |
Why?
|
Adenoviridae | 2 | 2023 | 1079 | 0.080 |
Why?
|
Gastroesophageal Reflux | 1 | 2016 | 803 | 0.080 |
Why?
|
Stents | 2 | 2018 | 3282 | 0.080 |
Why?
|
Deoxyguanosine | 1 | 2009 | 86 | 0.080 |
Why?
|
Early Diagnosis | 1 | 2013 | 1174 | 0.070 |
Why?
|
Respiratory Function Tests | 1 | 2010 | 1666 | 0.060 |
Why?
|
Disease-Free Survival | 2 | 2018 | 6781 | 0.060 |
Why?
|
Early Detection of Cancer | 1 | 2019 | 3124 | 0.060 |
Why?
|
Delivery of Health Care | 1 | 2022 | 5236 | 0.060 |
Why?
|
Case-Control Studies | 4 | 2020 | 21676 | 0.060 |
Why?
|
Length of Stay | 3 | 2022 | 6292 | 0.060 |
Why?
|
Respiration | 1 | 2010 | 1644 | 0.060 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 3 | 2019 | 11539 | 0.060 |
Why?
|
Tomography, X-Ray Computed | 3 | 2020 | 20145 | 0.050 |
Why?
|
Interleukins | 1 | 2006 | 772 | 0.050 |
Why?
|
Interleukin-7 | 1 | 2022 | 140 | 0.050 |
Why?
|
Time Factors | 3 | 2020 | 39589 | 0.050 |
Why?
|
Validation Studies as Topic | 1 | 2021 | 163 | 0.050 |
Why?
|
Antioxidants | 1 | 2009 | 1642 | 0.050 |
Why?
|
Activities of Daily Living | 1 | 2010 | 2371 | 0.050 |
Why?
|
Sleep Initiation and Maintenance Disorders | 1 | 2010 | 1030 | 0.050 |
Why?
|
Survival Rate | 3 | 2020 | 12632 | 0.040 |
Why?
|
Peptide Fragments | 1 | 2012 | 5031 | 0.040 |
Why?
|
Gastrostomy | 1 | 2021 | 316 | 0.040 |
Why?
|
Liver Diseases | 1 | 2006 | 1268 | 0.040 |
Why?
|
Prospective Studies | 3 | 2019 | 53219 | 0.040 |
Why?
|
Incidence | 3 | 2023 | 20812 | 0.040 |
Why?
|
Diagnosis, Differential | 1 | 2013 | 12839 | 0.040 |
Why?
|
Stomach | 1 | 2021 | 691 | 0.040 |
Why?
|
Young Adult | 3 | 2017 | 57114 | 0.040 |
Why?
|
Combined Modality Therapy | 2 | 2020 | 8509 | 0.040 |
Why?
|
Calcitonin | 1 | 2018 | 329 | 0.030 |
Why?
|
Tumor Cells, Cultured | 2 | 2016 | 6138 | 0.030 |
Why?
|
Lymphocytes, Tumor-Infiltrating | 1 | 2022 | 1061 | 0.030 |
Why?
|
Adrenocorticotropic Hormone | 1 | 2018 | 619 | 0.030 |
Why?
|
Ki-67 Antigen | 1 | 2018 | 635 | 0.030 |
Why?
|
Bronchi | 1 | 2019 | 842 | 0.030 |
Why?
|
Hyperthermia, Induced | 1 | 2019 | 412 | 0.030 |
Why?
|
Tumor Burden | 1 | 2019 | 1881 | 0.030 |
Why?
|
Sex Distribution | 1 | 2018 | 2258 | 0.030 |
Why?
|
Serotonin | 1 | 2018 | 1028 | 0.030 |
Why?
|
Lymph Node Excision | 1 | 2019 | 1277 | 0.030 |
Why?
|
Magnetic Resonance Imaging | 1 | 2020 | 35781 | 0.030 |
Why?
|
Immunoenzyme Techniques | 1 | 2016 | 1710 | 0.030 |
Why?
|
Liver | 1 | 2008 | 7371 | 0.030 |
Why?
|
Aorta | 1 | 2020 | 2027 | 0.020 |
Why?
|
Smoking | 1 | 2009 | 8975 | 0.020 |
Why?
|
ROC Curve | 1 | 2019 | 3496 | 0.020 |
Why?
|
Europe | 1 | 2018 | 3354 | 0.020 |
Why?
|
Peptides | 1 | 2023 | 4312 | 0.020 |
Why?
|
Endoscopy | 1 | 2021 | 1829 | 0.020 |
Why?
|
Adolescent | 3 | 2009 | 86212 | 0.020 |
Why?
|
Fibroblasts | 1 | 2021 | 4039 | 0.020 |
Why?
|
Propensity Score | 1 | 2017 | 1848 | 0.020 |
Why?
|
Mice | 3 | 2023 | 80065 | 0.020 |
Why?
|
Risk Assessment | 1 | 2011 | 23454 | 0.020 |
Why?
|
Animals | 4 | 2023 | 166308 | 0.020 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2016 | 4576 | 0.020 |
Why?
|
Tissue Distribution | 1 | 2012 | 2283 | 0.020 |
Why?
|
Blotting, Western | 1 | 2016 | 5048 | 0.020 |
Why?
|
Cross-Sectional Studies | 2 | 2020 | 25174 | 0.020 |
Why?
|
Recurrence | 1 | 2020 | 8373 | 0.020 |
Why?
|
Immunotherapy | 1 | 2023 | 4594 | 0.020 |
Why?
|
Hemorrhage | 1 | 2020 | 3522 | 0.020 |
Why?
|
Patient Satisfaction | 1 | 2020 | 3408 | 0.020 |
Why?
|
Immunohistochemistry | 1 | 2021 | 11037 | 0.020 |
Why?
|
Artificial Intelligence | 1 | 2021 | 2370 | 0.020 |
Why?
|
Kaplan-Meier Estimate | 1 | 2017 | 6453 | 0.020 |
Why?
|
Patient Selection | 1 | 2018 | 4192 | 0.020 |
Why?
|
Mice, Nude | 1 | 2012 | 3576 | 0.020 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2021 | 8904 | 0.010 |
Why?
|
Risk Factors | 2 | 2023 | 72413 | 0.010 |
Why?
|
Lung | 1 | 2022 | 9843 | 0.010 |
Why?
|
Prevalence | 1 | 2019 | 15306 | 0.010 |
Why?
|
RNA, Messenger | 1 | 2016 | 12742 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2016 | 10303 | 0.010 |
Why?
|
Apoptosis | 1 | 2016 | 9425 | 0.010 |
Why?
|
Disease Progression | 1 | 2016 | 13302 | 0.010 |
Why?
|